Production of polyfluoropropanols
    2.
    发明授权
    Production of polyfluoropropanols 失效
    生产聚氟丙烯

    公开(公告)号:US3714271A

    公开(公告)日:1973-01-30

    申请号:US3714271D

    申请日:1970-07-27

    Inventor: REGAN B

    CPC classification number: C07C29/58 C07C31/38

    Abstract: 1,1,3,3-Tetrafluoropropan-2-ol and 1,1,1,3,3-pentafluoropropan2-ol are prepared by the vapor phase catalytic halogen hydrogenolysis and carbonyl reduction of perhaloacetones with hydrogen employing a supported palladium on carbon catalyst.

    Abstract translation: 1,1,3,3-四氟丙-2-醇和1,1,1,3,3-五氟丙-2-醇通过汽相催化卤氢氢解和羰基还原全氢丙酮与氢气一起使用负载的钯制备 碳催化剂。

    5.
    发明专利
    未知

    公开(公告)号:DK125017B

    公开(公告)日:1972-12-18

    申请号:DK215369

    申请日:1969-04-21

    Inventor: REGAN B

    Abstract: 1,159,000. Inhalation anaesthetics. BAXTER LABORATORIES Inc. 1 March, 1967 [23 March, 19661, No. 9591/67. Heading A5B [Also in Division C2] Inhalation anaesthetic compositions comprise the compound in admixture with oxygen in suitable proportions for the production of anaesthetic and capable of supporting respiration. Other materials which may be present in the compositions are stabilisers, e.g. thymol, and known inhalation anaesthetics, e.g. nitrous oxide, ether, chloroiforim, halothane, cyclopropane and imethoxyflurane. The oxygen may be provided in the form of oxygen itself, air, or other gaseous mixtures containing oxygen.

    6.
    发明专利
    未知

    公开(公告)号:SE338307B

    公开(公告)日:1971-09-06

    申请号:SE395467

    申请日:1967-03-21

    Inventor: REGAN B

    Abstract: 1,159,000. Inhalation anaesthetics. BAXTER LABORATORIES Inc. 1 March, 1967 [23 March, 19661, No. 9591/67. Heading A5B [Also in Division C2] Inhalation anaesthetic compositions comprise the compound in admixture with oxygen in suitable proportions for the production of anaesthetic and capable of supporting respiration. Other materials which may be present in the compositions are stabilisers, e.g. thymol, and known inhalation anaesthetics, e.g. nitrous oxide, ether, chloroiforim, halothane, cyclopropane and imethoxyflurane. The oxygen may be provided in the form of oxygen itself, air, or other gaseous mixtures containing oxygen.

Patent Agency Ranking